Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

被引:65
|
作者
Derikx, Lauranne A. A. P. [1 ]
Nissen, Loes H. C. [1 ]
Smits, Lisa J. T. [1 ]
Shen, Bo [2 ]
Hoentjen, Frank [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Ctr Inflammatory Bowel Dis, POB 9101,Code 455, NL-6500 HB Nijmegen, Netherlands
[2] Cleveland Clin, Dept Gastroenterol Hepatol, Ctr Inflammatory Bowel Dis, Cleveland, OH 44106 USA
关键词
Ulcerative Colitis; Crohn's Disease; Epidemiology; Adenocarcinoma; Dysplasia; POUCH-ANAL ANASTOMOSIS; ULCERATIVE-COLITIS; ILEORECTAL ANASTOMOSIS; ILEAL-POUCH; RESTORATIVE PROCTOCOLECTOMY; SUBTOTAL COLECTOMY; RECTAL STUMP; PELVIC POUCH; COLORECTAL NEOPLASIA; SURGICAL-TREATMENT;
D O I
10.1016/j.cgh.2015.08.042
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Colorectal neoplasia can still develop after colectomy for inflammatory bowel disease. However, data on this risk are scare, and there have been few conclusive findings, so no evidence-based recommendations have been made for postoperative surveillance. We conducted a systematic review and meta-analysis to determine the prevalence and incidence of and risk factors for neoplasia in patients with inflammatory bowel disease who have undergone colectomy, including the permanent-end ileostomy and rectal stump, ileorectal anastomosis (IRA), and ileal pouch-anal anastomosis (IPAA) procedures. METHODS: We searched PubMed, Embase, Web of Science, and Cochrane Library through May 2014 to identify studies that reported prevalence or incidence of colorectal neoplasia after colectomy or specifically assessed risk factors for neoplasia development. Studies were selected, quality was assessed, and data were extracted by 2 independent researchers. RESULTS: We calculated colorectal cancer (CRC) prevalence values from 13 studies of patients who underwent rectal stump surgery, 35 studies of IRA, and 33 studies of IPAA. Significantly higher proportions of patients in the rectal stump group (2.1%; 95% confidence interval [CI], 1.3%-3.0%) and in the IRA group (2.4%; 95% CI, 1.7%-3.0%) developed CRC than in the IPAA group (0.5%; 95% CI, 0.3%-0.6%); the odds ratio (OR) for CRC in the rectal stump or IRA groups compared with the IPAA group was 6.4 (95% CI, 4.3-9.5). A history of CRC was the most important risk factor for development of CRC after colectomy (OR for patients receiving IRA, 12.8; 95% CI, 3.31-49.2 and OR for patients receiving IPAA, 15.0; 95% CI, 6.6-34.5). CONCLUSIONS: In a meta-analysis of published studies, we found the prevalence and incidence of CRC after colectomy to be less than 3%; in patients receiving IPAA it was less than 1%. Factors that increased risk of cancer development after colectomy included the presence of a residual rectum and a history of CRC. These findings could aid in development of individualized strategies for post-surgery surveillance.
引用
下载
收藏
页码:798 / U234
页数:29
相关论文
共 50 条
  • [31] The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis
    Zhu, Feng
    Li, Chuling
    Gong, Jianfeng
    Zhu, Weiming
    Gu, Lili
    Li, Ning
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (01) : 38 - 42
  • [32] Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis
    Wijnands, Anouk M.
    de Jong, Michiel E.
    Lutgens, Maurice W. M. D.
    Hoentjen, Frank
    Elias, Sjoerd G.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2021, 160 (05) : 1584 - 1598
  • [33] Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: An Agent-specific Systematic Review and Meta-analysis
    O'Connor, Anthony
    Packey, Christopher D.
    Akbari, Mona
    Moss, Alan C.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (11) : 2562 - 2569
  • [34] Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis
    Zhu, Zhehui
    Mei, Zubing
    Guo, Yuegui
    Wang, Guanghui
    Wu, Tingyu
    Cui, Ximao
    Huang, Zhenyu
    Zhu, Yilian
    Wen, Dongpeng
    Song, Jinglve
    He, Hailan
    Xu, Weimin
    Cui, Long
    Liu, Chenying
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (05): : 546 - 558
  • [35] The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis
    Qazi, Taha
    Amaratunga, Thelina
    Barnes, Edward L.
    Fischer, Monika
    Kassam, Zain
    Allegretti, Jessica R.
    GUT MICROBES, 2017, 8 (06) : 574 - 588
  • [36] Sleep quality in patients with inflammatory bowel disease: A systematic review and meta-analysis
    Barnes, A.
    Spizzo, P.
    Mountifield, R.
    Bampton, P.
    Andrews, J.
    Fraser, R. J.
    Mukherjee, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 101 - 101
  • [37] Inflammatory bowel disease in patients with Hirschsprung’s disease: a systematic review and meta-analysis
    H. Nakamura
    T. Lim
    P. Puri
    Pediatric Surgery International, 2018, 34 : 149 - 154
  • [38] Atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis
    Zuin, Marco
    Zuliani, Giovanni
    Rigatelli, Gianluca
    Del Favero, Giuseppe
    Roncon, Loris
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 76 : 120 - 122
  • [39] Predefined Diets in Patients with Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Comeche, Jose M.
    Gutierrez-Hervas, Ana
    Tuells, Jose
    Altavilla, Cesare
    Caballero, Pablo
    NUTRIENTS, 2021, 13 (01) : 1 - 22
  • [40] Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
    Abhyankar, Anita
    Moss, Alan C.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (08) : 1976 - 1981